Dr. Yasir Lal, MD

Dr. Lal practices at DaVita Sherman Dialysis Center in Sherman, Texas.

Dr. Lal's NPI, 1225220783, was assigned on August 17, 2007. Dr. Lal graduated from Allama Iqbal Medical College in 2002. Dr. Lal holds Texas license P8689.

Dr. Lal's primary practice is DaVita Sherman Dialysis Center, at 1724 W Us Hwy 82, Suite 100, Sherman, TX 75092 in Grayson County. The practice phone is (615) 928-3545. Dr. Lal also practices at Renal Treatment Centers-Southeast, 205 W Lamberth Rd, Sherman, TX 75092.

Dr. Lal's primary practice is DaVita Sherman Dialysis Center in Sherman, Texas. Dr. Lal is also affiliated with Sherman Medical Center. The medical group on file is Kidney Care Associates LLP. Dmand AI also links Dr. Lal to 4 more hospitals, 9 medical groups, 2 dialysis centers, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lal practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Lal's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Lal is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Lal's licenses on file in 5 states: Texas, South Dakota, Minnesota, North Dakota and Oklahoma.

Dmand AI lists acute kidney failure, chronic kidney disease, electrolyte disorders and fluid and electrolyte imbalances among the conditions Dr. Lal treats.

CMS data shows 2,161 Medicare services from Dr. Lal across 18 procedure codes in 2024, for 623 Medicare patients. Medicare paid $184,786 for them.

CMS counts 623 Medicare patients who saw Dr. Lal in 2024. The largest group is 75 to 84, with 213 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 3.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lal's median patient age at 70, with 49% women.

In 2024, Dr. Lal wrote 852 Medicare Part D claims for 185 patients. 86% of them were for generic drugs. CMS names the drug for 619 of them, across 23 drugs with 11 or more claims each, at $68,178 in total drug cost. In 2023, CMS named 318 claims across 15 drugs.

Dr. Lal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lal as offering telehealth.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Lal, published from 2011 to 2019. 2012 was the busiest year, with 2. The most frequent topics are Antithrombins, Benzimidazoles and Dabigatran. Dr. Lal has published most often in Am J Med Sci. Dr. Lal's most frequent co-authors are Salman Bangash, MD, Fred Clinton Lovrien, MD and Abdullah Mohammad Pervaiz, MD.

CMS Open Payments shows 53 general payments to Dr. Lal from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Medtronic, Inc. paid the most, $826.

Dr. Lal graduated from Allama Iqbal Medical College in 2002.

Dr. Lal is in network with 24 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.